Key Financial’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.13K Hold
100
– – ﹤0.01% 1066
2026
Q2
$5.37K Hold
100
– – ﹤0.01% 1008
2026
Q1
$4.82K Buy
+100
New +$6.84K ﹤0.01% 1039

Other funds holding GPCR

Key Financial's GPCR Position: Q3 2026 in Review

Key Financial held its Structure Therapeutics (GPCR) position steady in Q3 2026 at 100 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1066.

Key Financial first reported a position in GPCR in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.37K in Q2 2026. 113 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Key Financial held 100 shares of Structure Therapeutics worth $3.13K as of Q3 2026.
  • Key Financial left its Structure Therapeutics share count unchanged in Q3 2026.
  • Structure Therapeutics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1066 holding.
  • Key Financial first reported a position in Structure Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Key Financial's Structure Therapeutics position peaked at $5.37K in Q2 2026.
  • 113 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.